Studying tiny particles in cord blood of very premature babies
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Mother is 18 or older and speaks or understands French
- Baby is born before 28 weeks of pregnancy at Montpellier University Hospital
- Cord blood is collected right after birth
- Parents agree (do not say no) to the study before the sample is taken
- Baby is alive at birth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines heart development in babies born extremely early (22-28 weeks) compared to those born closer to full term (34+ weeks). It uses tissue samples from terminated pregnancies to understand how the heart matures.
This trial tests whether red blood cells made from donated cord blood are safe and effective for transfusions in extremely premature infants. It aims to see if this alternative blood source can help babies born before 28 weeks or weighing less than 1000 grams.
This trial tests whether a type of stem cell (mesenchymal stromal cells) can help prevent bronchopulmonary dysplasia, a serious lung condition, in very premature babies. Babies born before 28 weeks who are on a breathing machine with high oxygen needs may be eligible.
This study is testing a way to observe and rate the development of very premature babies. It is for babies born between 27 and 32 weeks, in good health, and whose families live near Toulouse.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
Hear when a new Intraventricular Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.